William Blair research analyst Margaret Kaczor was quoted as being “upbeat” by MedTech Dive following DexCom’s earnings call.
“While the company did not show a large inflection in growth yet, we believe that the strength this quarter sets the stage for what is still to come,” she wrote in her note to investors.